Medical Intelligence Announces Closing of Over-Allotment Option


    QUEBEC CITY, April 19 /CNW/ - Medical Intelligence Technologies Inc.
(TSX V: MIZ) announces that Canaccord Adams has partially exercised its
over-allotment option to purchase an additional 950,000 units in connection
with the previously announced public unit Offering that closed on April 18,
2007. Each Unit is comprised of one common share and one-half of one common
share purchase warrant at a price of $0.65 per Unit for gross proceeds of
$617,500. Each whole common share purchase warrant entitles the holder to
acquire one common share of Medical Intelligence at any time during the 18
months following the Closing Date at a price of $0.85. The partial exercise of
the over-allotment option increases the gross proceeds of the Offering to
    The Company intends to use the proceeds of the Offering primarily for
sales, marketing and business development initiatives, production of units,
research and development and for working capital.

    These securities have not been and will not be registered under the
    United States Securities Act of 1933, as amended, and subject to certain
    exemptions, may not be offered, sold or delivered, directly or
    indirectly, in the United States of America for the account or benefit of
    U.S. persons.

    About Medical Intelligence Technologies

    Medical Intelligence is the leader in the personal tele-security
industry, integrating information and telecommunications technologies to the
healthcare sector. The firm designs portable medical devices for the benefit
of people having health or safety concerns. Based in Quebec City, the Company
also has an office in Paris, where it commercializes the Columba bracelet with
cell phone operator Orange and in Madrid partnering with Telefonica Moviles
Espana. For further information, visit or

    Forward-looking statements

    Any statement in this press release that does not relate directly and
exclusively to historical facts can be considered a forward-looking statement.
Such statements reflect the intentions, plans, expectations and beliefs of
Medical Intelligence Technologies, and are subject to risks, uncertainties and
other factors that are largely beyond the Company's control, to the extent
that actual results may differ significantly from those contemplated by such
statements. Medical Intelligence Technologies neither intends nor is required
to update or revise such forward-looking statements based on new information
or future events, or for any other reason.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.

    %SEDAR: 00020559EF

For further information:

For further information: Quebec, Jean Brouillard Communications, (418)
682-6111,; Montreal, Johanne Lépine, Media Relations,
Torchia Communications, (514) 288-8290, ext. 234,;
Investor relations: Eric Bouchard, The Equicom Group Inc., (514) 844-7997,

Organization Profile

Medical Intelligence Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890